MARCH8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.50377496513465E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.60829999999291E-05 |
Normal-vs-Stage2 |
7.63790000000153E-05 |
Normal-vs-Stage3 |
1.52650003748533E-10 |
Normal-vs-Stage4 |
1.79622983154104E-12 |
Stage1-vs-Stage2 |
7.594300E-02 |
Stage1-vs-Stage3 |
8.019500E-04 |
Stage1-vs-Stage4 |
1.60790000003352E-06 |
Stage2-vs-Stage3 |
4.993000E-01 |
Stage2-vs-Stage4 |
5.085700E-02 |
Stage3-vs-Stage4 |
1.252760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.47589726498632E-11 |
Normal-vs-AfricanAmerican |
9.43599998137756E-09 |
Normal-vs-Asian |
2.981400E-01 |
Caucasian-vs-AfricanAmerican |
3.627800E-02 |
Caucasian-vs-Asian |
8.242000E-01 |
AfricanAmerican-vs-Asian |
2.735400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.77524661637563E-12 |
Normal-vs-Female |
2.44400000004585E-06 |
Male-vs-Female |
4.277600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.632200E-04 |
Normal-vs-Age(41-60Yrs) |
3.31649999685268E-08 |
Normal-vs-Age(61-80Yrs) |
2.03189687297822E-11 |
Normal-vs-Age(81-100Yrs) |
2.276100E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.838600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.659200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.393000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.431600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.093400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.821600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.883800E-01 |
Normal-vs-Grade 2 |
1.66430000003714E-06 |
Normal-vs-Grade 3 |
1.73820002835612E-09 |
Normal-vs-Grade 4 |
1.22124532708767E-15 |
Grade 1-vs-Grade 2 |
1.941970E-02 |
Grade 1-vs-Grade 3 |
7.479700E-03 |
Grade 1-vs-Grade 4 |
1.29820000005498E-06 |
Grade 2-vs-Grade 3 |
8.648100E-02 |
Grade 2-vs-Grade 4 |
7.60329999960341E-07 |
Grade 3-vs-Grade 4 |
3.968000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.594200E-02 |
Normal-vs-ccB subtype |
1.63447033685316E-12 |
ccA subtype-vs-ccB subtype |
8.70420002740957E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.51189999303614E-09 |
Normal-vs-N1 |
3.084100E-02 |
N0-vs-N1 |
3.984000E-01 |
|
|